MEDICI studie
A Double Blind, Randomized, Comparative Study of Obicetrapib and Bempedoic Acid on top of Maximally Tolerated Lipid-Lowering Therapy in Patients with Dyslipidaemia at Very High Cardiovascular Risk
- Stadium
- pijplijn
- Middel
- Obicetrapib
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 1 april 2026
- Last Patient In
- 1 februari 2027
- Last Patient Last Visit
- 1 juni 2026
Contact Bestuur
